Although there were no significant differences in the insulin requirements between the groups, eGDR levels were lower in patients with MS (6.63 mg/kg/min, IQR 4.79–8.59), when compared to the group without MS (8.42 mg/kg/min, IQR 7.49–9.67) (p < 0.001). The gene discussed is INS; the disease is myeloid sarcoma.